Search Results

Vivos Therapeutics, Inc. today announced two key strategic agreements that will expand Vivos’ current product line and are expected to create near term additional revenue opportunities.

Ormco Corporation, a global leader and innovator of orthodontic products and solutions, launches Ultima™ Hook, the first and only repositionable hook developed specifically for the Ultima wire.

Ormco Corporation , a global leader and innovator of orthodontic products and solutions, announces sole U.S. Distribution of the improved OrthoPulse® Gen.2 medical device.

Ormco Corporation announces the highly anticipated Spark Clear Aligners Release 14. Release 14 continues Spark’s philosophy of giving orthodontists control and flexibility.

Ormco Corporation today announced its introduction of a revolutionary passive self-ligation braces technology with the launch of its new Damon Ultima ™

Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.

Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.

Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.

Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”) today announced financial results and recent corporate highlights for the first quarter ended March 31, 2024.

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.